1. Home
  2. LTRN vs MNDO Comparison

LTRN vs MNDO Comparison

Compare LTRN & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$3.49

Market Cap

22.2M

Sector

Health Care

ML Signal

HOLD

Logo MIND C.T.I. Ltd.

MNDO

MIND C.T.I. Ltd.

HOLD

Current Price

$0.91

Market Cap

20.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTRN
MNDO
Founded
2013
1995
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
22.2M
20.0M
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
LTRN
MNDO
Price
$3.49
$0.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
280.3K
47.9K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
20.95%
EPS Growth
18.65
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$8.57
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$0.85
52 Week High
$5.74
$1.50

Technical Indicators

Market Signals
Indicator
LTRN
MNDO
Relative Strength Index (RSI) 72.90 34.06
Support Level $3.09 $0.89
Resistance Level $3.79 $1.24
Average True Range (ATR) 0.30 0.04
MACD 0.12 -0.00
Stochastic Oscillator 91.88 30.62

Price Performance

Historical Comparison
LTRN
MNDO

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

About MNDO MIND C.T.I. Ltd.

MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.

Share on Social Networks: